Evaluation of patients treated by telemedicine in the beginning of clinical trial preliminary study

We performed a pilot open-label, non-randomized controlled clinical trial in a clinic in Sa similar to o Paulo, Brazil in the beginning of the COVID-19 pandemic."This medical pilot project was carried out during the pandemic of a new and unknown agent. It was necessary to find a new and safe therapeutic approach for pathogens with high potential for severity and contamination. The repositioning of safe and accessible pre-existing and approved medications and the telemedicine approach improved treated covid patients' symptoms and reduced the risk of disease transmission. The emergency application of a new medical technology was the major limitation of the study. This innovative care model is a low-cost safe strategy, and we understand that applicability can be expanded to other regions in emergency situations."The 187 patients of the study (mean age of 37.6 +/- 15,6 years) were divided into four groups: (1) asymptomatic, (2) mild symptoms, (3) moderate symptoms and (4) severe symptoms and